Celgene Thalomid Initial Availability Will Be Limited to 500 Physicians
Celgene's Thalomid STEPS program will limit availability to 500 physicians and 500 pharmacies during the first three months of marketing.
You may also be interested in...
Risk management plans that include restricted distribution components should be limited to products that offer a unique benefit in a specific group of patients, according to FDA
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011